A Multifaceted Intervention to Improve Patient Knowledge and Safe Use of Opioids: Results of the ED EMC 2 Randomized Controlled Trial - PubMed

A Multifaceted Intervention to Improve Patient Knowledge and Safe Use of Opioids: Results of the ED EMC 2 Randomized Controlled Trial - PubMed

A Multifaceted Intervention to Improve Patient Knowledge and Safe Use of Opioids: Results of the ED EMC 2 Randomized Controlled Trial

Danielle M McCarthy 1, Laura M Curtis 2, D Mark Courtney 1, Kenzie A Cameron 2 3, Patrick M Lank 1, Howard S Kim 1, Lauren A Opsasnick 2, Abbie E Lyden 4, Stephanie J Gravenor 1, Andrea M Russell 2, Morgan R Eifler 2, Scott I Hur 2, Megan E Rowland 1, Surrey M Walton 5, Enid Montague 2 6, Kwang-Youn A Kim 3, Michael S Wolf 2

Affiliations 

• PMID: 31742823
 
• PMCID: PMC6901720 (available on 2020-12-01)
 
• DOI: 10.1111/acem.13860

Abstract

Objectives: Despite increased focus on opioid prescribing, little is known about the influence of prescription opioid medication information given to patients in the emergency department (ED). The study objective was to evaluate the effect of an Electronic Medication Complete Communication (EMC2 ) Opioid Strategy on patients' safe use of opioids and knowledge about opioids.

Methods: This was a three-arm prospective, randomized controlled pragmatic trial with randomization occurring at the physician level. Consecutive discharged patients at an urban academic ED (>88,000 visits) with new hydrocodone-acetaminophen prescriptions received one of three care pathways: 1) usual care, 2) EMC2 intervention, or 3) EMC2 + short message service (SMS) text messaging. The ED EMC2 intervention triggered two patient-facing educational tools (MedSheet, literacy-appropriate prescription wording [Take-Wait-Stop]) and three provider-facing reminders to counsel (directed to ED physician, dispensing pharmacist, follow-up physician). Patients in the EMC2 + SMS arm additionally received one text message/day for 1 week. Follow-up at 1 to 2 weeks assessed "demonstrated safe use" (primary outcome). Secondary outcomes including patient knowledge and actual safe use (via medication diaries) were assessed 2 to 4 days and 1 month following enrollment.

Results: Among the 652 enrolled, 343 completed follow-up (57% women; mean ± SD age = 42 ± 14.0 years). Demonstrated safe opioid use occurred more often in the EMC2 group (adjusted odds ratio [aOR] = 2.46, 95% confidence interval [CI] = 1.19 to 5.06), but not the EMC2 + SMS group (aOR = 1.87, 95% CI = 0.90 to 3.90) compared with usual care. Neither intervention arm improved medication safe use as measured by medication diary data. Medication knowledge, measured by a 10-point composite knowledge score, was greater in the EMC2 + SMS group (β = 0.57, 95% CI = 0.09 to 1.06) than usual care.

Conclusions: The study found that the EMC2 tools improved demonstrated safe dosing, but these benefits did not translate into actual use based on medication dairies. The text-messaging intervention did result in improved patient knowledge.

Trial registration: ClinicalTrials.gov NCT02431793.

© 2019 by the Society for Academic Emergency Medicine.

Comment in

• Opioid Prescribing From the ED: We Can All Do More to Help.

  Brucker K.Acad Emerg Med. 2019 Dec;26(12):1395-1396. doi: 10.1111/acem.13861. Epub 2019 Nov 19.PMID: 31742817 No abstract available.

Similar articles

• Electronic medication complete communication strategy for opioid prescriptions in the emergency department: Rationale and design for a three-arm provider randomized trial.

  McCarthy DM, Courtney DM, Lank PM, Cameron KA, Russell AM, Curtis LM, Kim KA, Walton SM, Montague E, Lyden AL, Gravenor SJ, Wolf MS.Contemp Clin Trials. 2017 Aug;59:22-29. doi: 10.1016/j.cct.2017.05.003. Epub 2017 May 4.PMID: 28479220 Clinical Trial.
• Improving patient knowledge and safe use of opioids: a randomized controlled trial.

  McCarthy DM, Wolf MS, McConnell R, Sears J, Chevrier A, Ahlstrom E, Engel KG, Cameron KA, Adams JG, Courtney DM.Acad Emerg Med. 2015 Mar;22(3):331-9. doi: 10.1111/acem.12600. Epub 2015 Mar 2.PMID: 25731073 Clinical Trial.
• Mobile phone text messaging to improve medication adherence in secondary prevention of cardiovascular disease.

  Adler AJ, Martin N, Mariani J, Tajer CD, Owolabi OO, Free C, Serrano NC, Casas JP, Perel P.Cochrane Database Syst Rev. 2017 Apr 29;4(4):CD011851. doi: 10.1002/14651858.CD011851.pub2.PMID: 28455948 Free PMC article. Review.
• Mobile phone messaging for facilitating self-management of long-term illnesses.

  de Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, Car J, Atun R.Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD007459. doi: 10.1002/14651858.CD007459.pub2.PMID: 23235644 Free PMC article. Review.
• The electronic medication complete communication (EMC2) study: Rationale and methods for a randomized controlled trial of a strategy to promote medication safety in ambulatory care.

  Bailey SC, Paasche-Orlow MK, Adams WG, Brokenshire SA, Hedlund LA, Hickson RP, Oramasionwu CU, Moore AL, McCarthy DM, Curtis LM, Kwasny MJ, Wolf MS.Contemp Clin Trials. 2016 Nov;51:72-77. doi: 10.1016/j.cct.2016.10.005. Epub 2016 Oct 22.PMID: 27777127 Free PMC article. Clinical Trial.